Compare LITS & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LITS | PRT |
|---|---|---|
| Founded | 2000 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.7M | 27.0M |
| IPO Year | 2003 | N/A |
| Metric | LITS | PRT |
|---|---|---|
| Price | $1.11 | $2.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 276.9K | 23.7K |
| Earning Date | 05-19-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 13.45% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.78 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.69 | $1.82 |
| 52 Week High | $3.03 | $4.01 |
| Indicator | LITS | PRT |
|---|---|---|
| Relative Strength Index (RSI) | 58.18 | 39.55 |
| Support Level | $0.97 | $2.02 |
| Resistance Level | $1.11 | $2.30 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 54.95 | 5.71 |
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.